secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2025-12-10T23:59:59+00:00
Accession:  0001213900-25-120197
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology raises $18M in registered direct & private placement; funds LYMPHIR launch
--------------------------------------------------------------------------------

- Gross proceeds ~$18M from sale of 1,284,404 shares at $1.09 + 15,229,358 pre-funded warrants at $1.0899 per unit.
- Net proceeds ~$15.2M after fees; H.C. Wainwright acted as placement agent (7% fee).
- Concurrent private placement includes warrants exercisable at $1.09 upon stockholder approval, 5-year term.
- Existing warrants for 11,961,040 shares amended to $1.09 exercise price and exercisable after stockholder approval.
- Citius Pharma promissory note maturity amended to require $50M of gross proceeds raised before maturity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025120197/0001213900-25-120197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025120197/ea0269093-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-120197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer